Skip to content

Comparison of the effects of dexmedetomidine, dexamethasone, fentanyl, and ketorolac on the quality and duration of supraclavicular block in distal radius surgery.

Comparison of administration of dexmedetomidine and dexamethasone, fentanyl and ketorolac with bupivacaine on duration of analgesia and quality of supraclavicular block in distal radius surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191104045328N46
Enrollment
132
Registered
2025-11-05
Start date
2025-11-11
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distal radius fracture surgery. Stress fracture, ulna and radius

Interventions

Intervention 1: Intervention Group 1: Patients in this group will receive dexmedetomidine at a dose of 1 µg/kg as an adjuvant, together with 20 mL of 0.5% bupivacaine. Dexmedetomidine (100 µg/2 mL
Exir Pharmaceutical Company, Borujerd, Iran) will be diluted with normal saline to a total volume of 5 mL after calculating the required dose, and then added to the local anesthetic solution to prepar
Caspian Tamin Pharmaceutical Company, Iran) will be diluted with normal saline to a total volume of 5 mL and then added to the local anesthetic solution to prepare a final volume of 25 mL for the supr
Aburaihan P

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients who are candidates for distal radius fracture surgery Having informed consent to participate in the study. Performing surgery on one side

Exclusion criteria

Exclusion criteria: Patients with additional fractures, major systemic diseases such as renal, hepatic, cardiovascular disorders, diabetes, hypertension, malignancy, and pregnancy Patients with neurological disorders of the hand, psychiatric diseases, or chronic pain syndrome Patients with coagulation disorders (abnormal PT, PTT, INR) History of allergy or drug hypersensitivity to the studied medications Use of narcotics or chronic analgesic medications

Design outcomes

Primary

MeasureTime frame
Pain score. Timepoint: During recovery and 2, 4, 8, 12, and 24 hours after surgery. Method of measurement: Visual analog scale.

Secondary

MeasureTime frame
Mean arterial pressure. Timepoint: Before the block and then every 15 minutes until the end of the surgery and during recovery and 2, 4, and 6 hours after the surgery. Method of measurement: NIBP monitoring device.;Heart rate. Timepoint: Before the block and then every 15 minutes until the end of the surgery and during recovery and 2, 4, and 6 hours after the surgery. Method of measurement: Cardiac monitoring device.;Arterial blood oxygen saturation. Timepoint: Before the block and then every 15 minutes until the end of the surgery and during recovery and 2, 4, and 6 hours after the surgery. Method of measurement: Pulse oximetry.;Onset of sensory block. Timepoint: After spinal anesthesia. Method of measurement: Using the pinprick test.;Onset of motor block. Timepoint: After spinal anesthesia. Method of measurement: Using the Bromage scale.;Duration of sensory block. Timepoint: After the sensory block ends. Method of measurement: watch.;Duration of motor block. Timepoint: After the motor block ends. Method of measurement: watch.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Alireza Susanabadi

Arak University of Medical Sciences

dr.susanabadi@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026